0 Comentários
0 Compartilhamentos
423 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Feed de notícias
- EXPLORAR
-
Páginas
-
Grupos
-
Eventos
-
Reels
-
Blogs
-
Marketplace
-
Offers
-
Jobs
-
Faça o login para curtir, compartilhar e comentar!
-
Biosimilar Bevacizumab Market – Oncology Cost Reduction and Access ExpansionMarket Overview The biosimilar bevacizumab market is transforming oncology care by offering substantially lower-cost alternatives to reference Avastin while maintaining equivalent efficacy and safety in treating colorectal, lung, breast, and glioblastoma cancers. Bevacizumab inhibits vascular endothelial growth factor, starving tumors of blood supply, but its high cost has limited access in...0 Comentários 0 Compartilhamentos 926 Visualizações 0 Anterior
-
Real World Evidence Solutions For Oncology Market Forecast for Advanced Oncology AnalyticsCancer research has traditionally depended heavily on controlled clinical trials, but the treatment experience that occurs outside those trials is generating an increasingly valuable source of evidence. Patients receive different therapies, move between care settings, respond differently to treatment, and experience outcomes over long periods that may not always be fully captured within...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
The Precision Oncology Frontier: How the Hematological Malignancies Disease Market Is Advancing Blood Cancer CareBlood cancers, including leukemia, lymphoma, and myeloma, represent a significant and growing global health challenge. However, the treatment landscape for these malignancies is undergoing a profound transformation, moving from traditional chemotherapy towards more precise, targeted, and immune-based therapies. The Hematological Malignancies Disease Market, valued at USD 29.6 Billion in 2025,...0 Comentários 0 Compartilhamentos 699 Visualizações 0 Anterior
-
Advancing Canine Mast Cell Tumors Treatment: The Growing Veterinary Oncology MarketThe field of veterinary oncology has witnessed remarkable progress in recent years, with increased attention focused on the diagnosis and treatment of cancer in companion animals. Among the most common and challenging cancers in dogs are mast cell tumors, which represent a significant area of focus for veterinary oncologists and pharmaceutical developers. The canine mast cell...0 Comentários 0 Compartilhamentos 683 Visualizações 0 Anterior
-
Advancing PD-1 Inhibitor Therapy: The Growing Immuno-oncology Drugs MarketThe field of oncology has been revolutionized by the development of immuno-oncology drugs, with PD-1 inhibitors emerging as a cornerstone of cancer treatment. Tislelizumab, a novel PD-1 inhibitor, offers a targeted approach to immunotherapy, enhancing the body's immune response against cancer cells. The PD-1 inhibitor therapy market is experiencing remarkable growth, with projections...0 Comentários 0 Compartilhamentos 500 Visualizações 0 Anterior
-
AI in Oncology Market Trends: Digital Pathology and AI-Powered Cancer AnalysisPolaris Market Research today announced findings from its latest report, projecting the global AI in Oncology market to grow from USD 6.51 billion in 2025 to USD 56.44 billion by 2034, at a CAGR of 27.1%. The report profiles 10 leading companies across multiple market segments, benchmarking the global AI in oncology landscape across component, application, and regional lines. The market covers...0 Comentários 0 Compartilhamentos 444 Visualizações 0 Anterior
-
Bcl-2 (B-Cell Lymphoma 2) Inhibitors Market – Targeted Apoptosis Therapy Advancing Oncology CareMarket Overview Cancer treatment continues to advance through therapies that restore the body's natural cell death mechanisms in malignant cells. The Bcl-2 (B-Cell Lymphoma 2) Inhibitors Market is growing as oncologists incorporate Bcl-2 inhibitor therapies into treatment regimens for hematologic malignancies where cancer cells evade normal apoptotic signaling. Hematology-oncology centers...0 Comentários 0 Compartilhamentos 670 Visualizações 0 Anterior
-
BCL-2 Family Inhibitors and Targeted Cell-Death Therapies Transforming the Oncology Apoptosis Modulator MarketTargeting cell-death evasion pathways to restore natural programmed cell death in malignant cells represents a cornerstone of modern targeted cancer therapy within the Oncology Apoptosis Modulator Market. Apoptosis modulators encompass small-molecule BCL-2 inhibitors (such as venetoclax), MCL-1 inhibitors, and IAP antagonists that disrupt anti-apoptotic protein complexes inside tumor cells....0 Comentários 0 Compartilhamentos 301 Visualizações 0 Anterior
-
Beyond Antigens: The Expanding Role of mRNA and Personalized Vaccines in the Oncology MarketThe global oncology market is witnessing a significant paradigm shift towards highly personalized, technology-driven therapeutic approaches. The mRNA and Personalized Cancer Vaccines in the Oncology Market represents a critical and rapidly evolving segment, driven by the need to overcome tumor heterogeneity and deliver tailored treatments. With the overall cancer vaccines market...0 Comentários 0 Compartilhamentos 487 Visualizações 0 Anterior
-
Biobetters Market: Next-Generation Antibody-Drug Conjugates (ADCs) in Precision OncologyEscalating oncology clinical trials, technological breakthroughs in site-specific bioconjugation, and demand for targeted tumor eradication are fueling momentum in the oncology sector of the Biobetters Market. Engineered antibody-drug conjugates act as biological guided missiles, delivering potent cytotoxic payloads selectively to tumor cells. In addition, second-generation ADC biobetters...0 Comentários 0 Compartilhamentos 157 Visualizações 0 Anterior
-
Biosimilar Bevacizumab Market – Affordable Oncology Care Increasing Treatment AccessMarket Overview Cancer care can place significant financial pressure on patients, hospitals, insurers, and national healthcare systems. Biologic medicines have transformed treatment in many oncology settings, but their high cost can restrict access or strain budgets. Biosimilars are designed to be highly similar to approved reference biologic medicines, with no clinically meaningful differences...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Companion Diagnostics Market Growth Through Biomarker-Guided TreatmentThe companion diagnostics market is becoming an increasingly important link between diagnosis and treatment. Instead of asking only whether a disease is present, modern healthcare is increasingly asking a more specific question: which therapy is most appropriate for this patient? That change is reshaping the role of diagnostics. A biomarker can now influence whether a targeted drug is...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Injectable Targeted Therapy Market Size, Share, Trends & Forecast 2033According to the latest report published by Data Bridge Market Research, the Injectable Targeted Therapy Market CAGR Value Injectable Targeted Therapy Market survey report is intended to help the readers develop a practical and intelligent approach to market dynamics and exploit opportunities, therefore. The market report also contains the drivers and restraints for the...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Advances in Targeted Cancer Therapies Create New Opportunities for Market PlayersThe increasing global prevalence of cancer, growing adoption of targeted therapies, and continuous advancements in pharmaceutical research are driving the global Oncology Drugs Market. Oncology drugs play a critical role in cancer treatment by targeting cancer cells, slowing disease progression, and supporting improved patient outcomes. These medicines include chemotherapy, targeted therapy,...0 Comentários 0 Compartilhamentos 30 Visualizações 0 Anterior
-
Artificial Intelligence in Precision Medicine Market Outlook Through 2033The Artificial Intelligence in Precision Medicine Market is entering a high-growth phase as healthcare providers and pharmaceutical companies increasingly use AI to understand disease biology, predict treatment responses, and develop therapies tailored to individual patients. Artificial Intelligence in Precision Medicine Market Valued at USD 2.4 billion in 2025, the market is projected to...0 Comentários 0 Compartilhamentos 698 Visualizações 0 Anterior
-
Bevacizumab Market Outlook: Key Trends & Future GrowthAccording to the latest report published by Data Bridge Market Research, the Coal Tar Market CAGR ValueThe coal tar market size was valued at USD 16.54 billion in 2024 and is expected to reach USD 20.47 billion by 2032, at a CAGR of 2.70% during the forecast period. The large scale Coal Tar Market report evaluates CAGR value fluctuation during the forecast period for the market. All the...0 Comentários 0 Compartilhamentos 9 Visualizações 0 Anterior
-
Bevacizumab Market: Growth Drivers, Trends & Emerging OpportunitiesAccording to the latest report published by Data Bridge Market Research, the Bevacizumab Market CAGR ValueData Bridge Market Research analyses that the market, which was USD 6,679.14 million in 2022, would rocket up to USD 12,967.08 million by 2030 and is expected to undergo a CAGR of 9.20% during the forecast period. A talented team works strictly with their potential capabilities to...0 Comentários 0 Compartilhamentos 7 Visualizações 0 Anterior
-
Breakthrough Drug Developments Creating New Opportunities in Immuno OncologyThe North America Immuno-Oncology Drugs Market is expanding as advances in immunology and biotechnology contribute to the development of innovative cancer therapies. Researchers are investigating treatments that enhance immune responses, overcome tumor immune evasion, and improve therapeutic outcomes for selected patient populations. Increasing clinical trial activity, pharmaceutical research...0 Comentários 0 Compartilhamentos 412 Visualizações 0 Anterior
-
Cancer Registry Software Market Forecast and Growth Opportunities to 2034Cancer Registry Software Market Overview The global Cancer Registry Software Market is experiencing significant growth due to the increasing prevalence of cancer, the growing demand for effective cancer data management, and the rising adoption of digital healthcare technologies. Cancer registry software helps healthcare organizations collect, store, manage, and analyze information about...0 Comentários 0 Compartilhamentos 408 Visualizações 0 Anterior
-
CAR-T Cell Therapy Market: Growth Drivers, Trends & OpportunitiesAccording to the latest report published by Data Bridge Market Research, the Chimeric Antigen Receptor (CAR)-T Cell Therapy Market CAGR ValueAs per Data Bridge Market Research Analysis the global chimeric antigen receptor (CAR)-T cell therapy market size was valued at USD 2.72 billion in 2024 and is expected to reach USD 6.65 billion by 2032, at a CAGR of 11.80% during the...0 Comentários 0 Compartilhamentos 12 Visualizações 0 Anterior
-
Chemotherapy at Home Services Market: Home Cancer Care TrendsChemotherapy at Home Services Market: Growth, Trends, Demand & Forecast to 2034 Chemotherapy at Home Services Market Snapshot The Chemotherapy at Home Services Market is emerging as an important segment of decentralized cancer care, supported by the growing demand for convenient treatment options, advances in home healthcare infrastructure, and increasing interest in...0 Comentários 0 Compartilhamentos 4KB Visualizações 0 Anterior
Páginas impulsionada